stopOverflowHandler
PROCESS TO OBTAIN PORPHYRIN DERIVATIVES FOR RADIOIMMUNOTHERAPY
Principal Investigator: B. BOITREL
TECHNICAL DESCRIPTION

This invention describes the preparation of new chelating molecules from a common porphyrinoïd backbone, with specific applications in the coordination of alpha particle emission radionucleides. These new chelates can stabilize metals such as bismuth or lanthanides and have been designed to be linked to a monoclonal antibody, for targeting of specific cells. In some instances, the same molecule can be used both as the chelating agent and the link between two antibody fragments.


To read more, please register or connect in the right pannel...
 
< Prev   Next >
 
 

Identification






Direct Access
+33 1 40 51 00 90
Biovaria 2012, Munich, Germany 15th May 2012

The marketplace for life-science technologies from leading European research institutions and ...
Details ...



BIO International Convention 2012

Rencontrez-nous du 18 au 21 juin 2012 à la Convention d’Affaires Internationale « BIO International ...
Details ...



 
   
viagra 100mg